Auditor14 May 2026, 02:08 pm
Akums Drugs Appoints Mahajan & Aibara as Internal Auditors
AI Summary
Akums Drugs and Pharmaceuticals Ltd has appointed Mahajan & Aibara LLP, Chartered Accountants, as their Internal Auditors for the financial year 2026-27. This decision was made during the Board of Directors meeting held on May 14, 2026. The board also approved the re-appointment of M/s. Balwinder & Associates as Cost Auditors and recommended final and special dividends for FY 2026.
Key Highlights
- Mahajan & Aibara LLP appointed as Internal Auditors for FY 2026-27.
- Balwinder & Associates re-appointed as Cost Auditors for FY 2026-27.
- Final dividend of ₹1.00 and special dividend of ₹2.00 per share recommended for FY 2026.
- Record date for dividend eligibility fixed as July 03, 2026.
- V Jagannathan appointed as Senior Management Personnel; Arvind Srivastava ceased from the role.
Price Impact
More from AKUMS